4/A: Bradley Keywell Reports Amended Securities Transactions in Tempus AI, Inc. (TEM)

Bradley Keywell, a director and 10% owner of Tempus AI, Inc., filed an amended Form 4 detailing multiple sales of Class A Common Stock between January 15 and January 17, 2025, and indicating he is no longer subject to Section 16.

Summary

• Bradley Keywell, a director and 10% owner of Tempus AI, Inc. (TEM), filed an amended Form 4 with the SEC.
• The form details multiple transactions involving the sale of Class A Common Stock.
• These transactions occurred between January 15, 2025, and January 17, 2025.
• The sales were executed at varying prices, ranging from approximately $34.75 to $36.24 per share.
• The total number of shares sold indirectly through BK TL21 LLC was 945,934.
• Following these transactions, BK TL21 LLC indirectly holds 15,218,365 shares.
• Keywell indicates that he is no longer subject to Section 16 reporting requirements.
• The filing amends a previous Form 4 filed on January 17, 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the insider selling a significant number of shares. While not inherently alarming, it warrants monitoring for further transactions or explanations.

Negatives

• A director and significant shareholder is selling a notable amount of shares, which could be perceived negatively by the market.

Risks

• Continued sales of shares by Keywell could put downward pressure on the stock price.
• The reason for Keywell no longer being subject to Section 16 is not explicitly stated and could raise questions.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into management's perspective on the company's prospects. Large sales by insiders can sometimes raise concerns, while purchases are often seen as a positive signal.

Comparison to Industry Standards

• It's common for executives and major shareholders to periodically adjust their holdings in publicly traded companies.
• The significance of these transactions often depends on the size of the sale relative to their total holdings and the context of the company's performance and outlook.
• Comparable companies such as Exact Sciences (EXAS) and Guardant Health (GH) also see regular insider trading activity; however, the impact on stock price varies based on market sentiment and company-specific news.

Stakeholder Impact

• Shareholders may react to the insider selling, potentially leading to short-term price volatility.
• Employees may be concerned about the reasons behind the sale, although the impact is likely to be minimal unless part of a larger trend.

Key Dates